Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cance... ( SAN FRANCISCO June 11 /- Jennerex Inc...)

HOME >> MEDICINE >> TECHNOLOGY

Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research

Date:6/11/2009

SAN FRANCISCO, June 11 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Canada), a clinical-stage biopharmaceutical company, announced today that a $10 million grant from the Ontario Institute for Cancer Research (OICR) has been received by the Centre for Cancer Therapeutics at Ottawa Hospital Research Institute (OHRI). A large portion of this grant will fund research and development in the lab of Dr. John Bell, Jennerex's chief collaborator for the discovery and development of oncolytic viral therapeutics for cancer patients. Funding will support the translation of discoveries into medical products with the potential to prolong the lives of cancer patients. The grant, which provides $10 million (CAD) over four years, will fund the research and development of novel therapeutics including the development of Jennerex's oncolytic viral therapy products. Jennerex products have shown tumor destruction and safety in Phase 1 and 2 clinical trials.

"We are very pleased that Dr. Bell and Jennerex's oncolytic virus technologies have been given this vote of confidence by the Ontario Institute for Cancer Research. This funding will bolster the translation of Dr. Bell's promising research into important cancer therapeutics," stated David H. Kirn, M.D., president and chief executive officer of Jennerex. "We believe that there is significant potential in Ontario for medical innovation and development, and we value our partnerships in Ontario a great deal."

"This collaboration has been a great example of academia and industry working together to translate biological research into cutting edge therapies quickly and effectively," said Dr. John Bell, Senior Scientist at the Ottawa Hospital Research Institute and Professor of Medicine at the University of Ottawa.

Jennerex is conducting Phase 2 clinical trials for several types of cancer in Ontario, Canada. In addition, the company has a strong and co
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
4. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
5. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria

Post Your Comments:

(Date:5/21/2013)... VIEW, Calif. , May 21, 2013 /PRNewswire/ ... design and manufacture of wireless personal healthcare products ... broaden its reach, announcing the release of two ... wireless blood pressure monitors and scales: the Wireless ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...

(Date:5/21/2013)... , May 21, 2013 Vasomedical, Inc. (OTC BB: VASO) ... design, manufacture and sale of medical devices and in the ... Jun Ma , President and CEO of ... MicroCap Conference on Thursday, May 30, 2013 in ... The Company,s presentation is scheduled to begin ...

(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue: ... for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... to offer synopsis of the current and ...

[0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)

... 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported ... Arena reported a lower net loss allocable to common stockholders in ... share, compared to a net loss allocable to common stockholders in ... share, and a net loss allocable to common stockholders in the ...

... TessArae® LLC, a global leader in resequencing microarray-based ... solutions for genetic testing of the mutations that ... TessArae,s expertise in microarray-based resequencing with novel nucleotide ... for all targeted mutations in multiple genes of ...

Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments TessArae Delivers Lower Cost Option to Genetic Testing Market

(Date:5/21/2013)... Aurora, CO (PRWEB) May 22, 2013 ... (AHWC) is teaming up with HEALTHY DINING to help ... , The new program is called HEALTHY ... with 300 locations are already participating in Colorado. Restaurants ... for kids and adults emphasizing lean protein, vegetables, fruits, ...

(Date:5/21/2013)... Colorado Springs, CO (PRWEB) May 22, 2013 ... a plan for better nutrition--from farmers' markets filled with ... help consumers make the most of the season the ... for a healthier lifestyle not to miss. , 1. ... and weather that invites shoppers to linger and explore, ...

(Date:5/21/2013)... Swimsuit season is almost here. The "Get Ready for ... with a 35% discount. , Cellulite forms mainly in women ... dreaded cellulite even if they are in shape. Cellulite ... been stored as toxic lymph and smashed together, giving the ... program that works to dissolve the toxins and fatty deposits ...

(Date:5/21/2013)... Bradley, Illinois (PRWEB) May 21, 2013 ... living community], a BMA affordable assisted living community, is hosting ... Don'ts of Arthritis at 2 p.m. on Tuesday, May 28. ... in Dwight, Illinois, serves older adults of all incomes, including ... independence. , The Arthritis program is open to the public. ...

(Date:5/21/2013)... 22, 2013 Feed additives have now ... industry value chain. Most of the feed additives are ... pellets, liquids, and powders. There are variety of feed ... concentrations depending upon the type of animal and feed. ... that provide essential nutrition to the animal in order ...

Breaking Medicine News(10 mins):Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2 Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3 Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2 Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3 Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2 Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4

[0] Colorado Takes a Huge Step toward Transforming the Family Dining Experience [0] Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring [0] Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale"[0] Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis [0] Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com

... is crucial to provide quality care to patients. In ... nearly 10% of scan results never reach the doctors ... year 2005/2006. ,Worse still, the results reach ... in some cases a tacit agreement between the department ...

... The 2003 severe acute respiratory syndrome (SARS) epidemic in ... prevent the spread of other respiratory diseases// , according ... of Clinical Infectious Diseases, currently available online. ... and Hong Kong in 2003. In hospitals with especially ...

... called applied relaxation training (ART); however, a recent study ... an age old technique employed since the 20th century, ... the study, 49 patients were given psychotherapy twice a ... training helped patients pick up ways to relax the ...

... drugs created in the last quarter century, say David Newman ... of the National Cancer Institute (NCI) of the USA. ... through June 2006 for all diseases worldwide. The list included 1,184 ... thirty percent of the new drugs were totally synthetic in origin. ...

... don't cause the pain and bruising common with existing ... California. ,In a bid to confront the ... and discomfort experienced by patients, a team of researchers ... painless, needle-free drug delivery system in collaboration with drug ...

... method in ultrasound known as "eSie Touch Elasticity Imaging" ... ECR 2007 (European Congress of Radiology) in Vienna//, Austria. ... adjunct to regular breast ultrasound examinations, may provide a ... method is currently being tested in several studies with ...

Cached Medicine News:Health News:Study Identifies Risk Factors for Spread of Respiratory Infections in Hospitals 2 Health News:Micro-jets for Painless Needle-free Injections 2 Health News:Micro-jets for Painless Needle-free Injections 3 Health News:eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies 2

Testing Time for Patients - Undue Delays in Getting Test Results Study Identifies Risk Factors for Spread of Respiratory Infections in Hospitals Talk Your Way Out of Panic Attacks Nature Behind Most New Drugs Micro-jets for Painless Needle-free Injections eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

Medicine Products:

Immunofixation Electrophoresis, Urine Immunocytochemistry ImmuKnow Immune Cell Function Assay IL-6 Response to Antigens and/or Mitogens